| Name | Inaxaplin |
|---|
| Description | Inaxaplin is an apolipoprotein L1 (APOL1) function inhibitor (WO2020131807, compound 2). Inaxaplin can be used for the research of kidney disease[1]. |
|---|---|
| Related Catalog | |
| Target |
APOL1[1] |
| In Vitro | Inaxaplin is an apolipoprotein L1 function inhibitor[1]. |
| References |
[1]. WO2020131807 |
| Molecular Formula | C21H18F3N3O3 |
|---|---|
| Molecular Weight | 417.38 |